STOCK TITAN

VALERIO THERAPEUTICS: List of the Board Members Positions Held in Other Companies as of March 19, 2025

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
management

VALERIO THERAPEUTICS, a French pharmaceutical company headquartered in Paris, has disclosed information regarding its board members' positions in other companies as of March 19, 2025. The company, which operates with a share capital of €21,610,998.20, is structured as a société anonyme (French public company) with a board of directors. The company's registered office is located at 49 boulevard du Général Martial Valin in Paris's 15th arrondissement.

VALERIO THERAPEUTICS, un'azienda farmaceutica francese con sede a Parigi, ha reso note le informazioni riguardanti le posizioni dei membri del suo consiglio di amministrazione in altre aziende al 19 marzo 2025. L'azienda, che opera con un capitale sociale di €21.610.998,20, è strutturata come una société anonyme (società per azioni francese) con un consiglio di amministrazione. La sede legale dell'azienda si trova al 49 boulevard du Général Martial Valin nel 15° arrondissement di Parigi.

VALERIO THERAPEUTICS, una empresa farmacéutica francesa con sede en París, ha divulgado información sobre las posiciones de sus miembros del consejo en otras empresas a partir del 19 de marzo de 2025. La empresa, que opera con un capital social de €21.610.998,20, está estructurada como una société anonyme (sociedad anónima francesa) con un consejo de administración. La oficina registrada de la empresa se encuentra en el 49 boulevard du Général Martial Valin en el 15° arrondissement de París.

VALERIO THERAPEUTICS는 파리에 본사를 둔 프랑스 제약 회사로, 2025년 3월 19일 기준으로 이사회 구성원들이 다른 회사에서 맡고 있는 직책에 대한 정보를 공개했습니다. 이 회사는 €21,610,998.20의 자본금으로 운영되며, 프랑스의 주식회사 형태인 société anonyme로 구성되어 있습니다. 회사의 등록 사무소는 파리 15구의 49 boulevard du Général Martial Valin에 위치하고 있습니다.

VALERIO THERAPEUTICS, une entreprise pharmaceutique française dont le siège est à Paris, a divulgué des informations concernant les postes de ses membres du conseil d'administration dans d'autres entreprises au 19 mars 2025. L'entreprise, qui opère avec un capital social de 21 610 998,20 €, est structurée en tant que société anonyme avec un conseil d'administration. Le siège social de l'entreprise est situé au 49 boulevard du Général Martial Valin dans le 15e arrondissement de Paris.

VALERIO THERAPEUTICS, ein französisches Pharmaunternehmen mit Sitz in Paris, hat am 19. März 2025 Informationen über die Positionen seiner Vorstandsmitglieder in anderen Unternehmen veröffentlicht. Das Unternehmen, das mit einem Aktienkapital von 21.610.998,20 € operiert, ist als société anonyme (französische Aktiengesellschaft) strukturiert und verfügt über einen Vorstand. Der eingetragene Sitz des Unternehmens befindet sich in der 49 boulevard du Général Martial Valin im 15. Arrondissement von Paris.

Positive
  • None.
Negative
  • None.

PARIS--(BUSINESS WIRE)-- Regulatory News:

VALERIO THERAPEUTICS (Paris:ALVIO):

 Name of Director

Other offices and functions

 

Julien MIARA

Chief Executive Officer and Director

 

  • Managing Director at Invus
  • Director of Sensorion
  • Director of Versity

 

Jacques MALLET

Director and Chairman of the Board

 

  • Chairman of Gamma-X Corporate Advisory
  • Director of Technoflex
  • Director of the Fournier Majoie Foundation

 

FINANCIERE DE LA MONTAGNE, represented by Nicolas TREBOUTA

Director

 

  • Manager of SARL Financière de la Montagne
  • Manager of SCI Fleurus Immobilier
  • Chairman of SAS Dragon 8
  • Managing partner of SC Financière des Associés
  • Chairman of the Supervisory Board of SCA Chevrillon & Associés
  • Manager of EARL Ferme de Bissy
  • Managing partner of SC Valois
  • Co-manager of SC Aster
  • Managing partner of SCI du Chardonnet

 

Bryan GIRAUDO

Director

 

  • Chief Operating Officer and Chief Financial Officer of Gossamer Bio Inc
  • Director of Protagonist Therapeutics
  • Senior Managing Director at Leerink Partners

Antoine BAROUKY

Chief Operating Officer and Director

  • Chairman & CEO of MAAsiRNA
  • Chairman & CEO of AB Global Strategy
  • Venture Partner at Invus

 

Shefali AGARWAL

Director

 

  • Member of the Board of Directors of ITB Med (unlisted)
  • Member of the Board of Directors of Gritstone Bio (Nasdaq: GTRS)
  • Member of the Board of Directors of Fate Therapeutics (Nasdaq: FATE)

VALERIO THERAPEUTICS
Société anonyme à conseil d’administration au capital social de 21.610.998,20 euros
Siège social : 49 boulevard du Général Martial Valin, 75015 Paris 410 910 095 R.C.S. Paris

VALERIO THERAPEUTICS

Source: VALERIO THERAPEUTICS

FAQ

What is the current share capital of VALERIO THERAPEUTICS (GTRS) as of March 2025?

VALERIO THERAPEUTICS has a share capital of €21,610,998.20 as of March 19, 2025.

Where is VALERIO THERAPEUTICS (GTRS) headquartered?

VALERIO THERAPEUTICS is headquartered at 49 boulevard du Général Martial Valin, 75015 Paris, France.

What type of corporate structure does VALERIO THERAPEUTICS (GTRS) have?

VALERIO THERAPEUTICS is structured as a société anonyme (French public company) with a board of directors.

What is VALERIO THERAPEUTICS' (GTRS) registration number in Paris?

VALERIO THERAPEUTICS' registration number is 410 910 095 R.C.S. Paris.
GTRS

:GTRS

GTRS Rankings

GTRS Stock Data